Genetic and companion testing takes a village, according to Jan Berger, MD, MJ, president and chief executive officer of Health Intelligence Partners and editor-in-chief of The American Journal of Pharmacy Benefits.
Genetic and companion testing takes a village, according to Jan Berger, MD, MJ, president and chief executive officer of Health Intelligence Partners and editor-in-chief of The American Journal of Pharmacy Benefits.
Not only do the providers need to be in line, but so do the genetic counselors — if they’re available — and the industry is struggling with that as well as knowing the right processes to go through, she explained.
“So I think we need to come to a consensus on the right timing and the right process to put this all together to get the outcomes we’re looking for,” Dr Berger said.
Subjective and Objective Impacts of Ambulatory AI Scribes
January 8th 2026Although the vast majority of physicians using an artificial intelligence (AI) scribe perceived a reduction in documentation time, those with the most actual time savings had higher relative baseline levels of documentation time.
Read More